Aurora Cannabis (TSE:ACB) Cut to Sell at TD

TD lowered shares of Aurora Cannabis (TSE:ACB) from a buy rating to a sell rating in a research report sent to investors on Wednesday,BayStreet reports. They currently have C$7.80 price target on the stock, down from their previous price target of C$8.00.

ACB has been the topic of several other reports. ATB Cormark Capital Markets increased their price target on shares of Aurora Cannabis from C$5.60 to C$7.00 and gave the stock a “tender” rating in a research report on Tuesday, October 6th. BMO Capital Markets upgraded Aurora Cannabis to a “hold” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, Aurora Cannabis has an average rating of “Reduce” and an average target price of C$6.60.

Aurora Cannabis Stock Up 1.5%

Shares of TSE ACB traded up C$0.11 on Wednesday, reaching C$7.40. 795,641 shares of the company’s stock traded hands, compared to its average volume of 421,858. Aurora Cannabis has a 12 month low of C$3.59 and a 12 month high of C$8.75. The company has a quick ratio of 2.48, a current ratio of 5.36 and a debt-to-equity ratio of 4.30. The company has a market cap of C$468.49 million, a price-to-earnings ratio of -3.81 and a beta of 0.26. The business’s 50 day simple moving average is C$5.83 and its two-hundred day simple moving average is C$4.96.

Aurora Cannabis (TSE:ACB) last issued its earnings results on Thursday, November 5th. The company reported C$0.05 EPS for the quarter. Aurora Cannabis had a negative return on equity of 5.21% and a negative net margin of 9.53%. The business had revenue of C$86.02 million for the quarter. As a group, equities research analysts forecast that Aurora Cannabis will post -0.22 EPS for the current fiscal year.

Aurora Cannabis Company Profile

Aurora is Opening the World to Cannabis ¿, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company’s adult-use brand portfolio includes Drift , San Raf , Daily Special ¿, Tasty’s ¿, Being and Greybeard . Medical cannabis brands include MedReleaf , CanniMed , Aurora and Whistler Medical Marijuana Corporation , as well as international brands, Pedanios , IndiMed ¿ and CraftPlant ¿.